For most employers, pharmacy feels like a simple equation: more prescriptions = more cost. 

Utilization goes up, spend follows. That’s been the assumption for years. But what we’re seeing across parts of the market—and within MJ’s CaptuRe captive—is challenging that thinking.  

It’s possible to have more utilization and lower costs at the same time. 

In many plans, pharmacy strategy has been reactive. 

Costs rise → access tightens → employees pay more or use less. 

But this approach doesn’t address the real issue: Not all utilization drives cost in the same way.  

There’s a big difference between the right medication at the right cost and a high-cost drug used without oversight or strategy.  Lump those together, and you might get the idea that all usage is bad for the plan. 

Employers that are outperforming in pharmacy aren’t focused on reducing utilization—they’re focused on directing it. That shift changes the outcome. 

Instead of asking, “How do we cut back?” they’re asking: “How do we make sure every dollar spent on pharmacy is working harder?” 

Within MJ’s employee benefits captive, CaptuRe, that approach is playing out clearly: Pharmacy utilization is increasing while overall costs are improving relative to expectations. 

Not because members are using less but because they’re using smarter, better-managed solutions.  

Successfully keeping cost down as usage rises comes down to strategy and consistency. A few key levers are making the difference. 

The common thread: intentional management, not passive coverage. 

For years, pharmacy strategy was built around limits—restrict access, increase cost-share, reduce use. But that approach can create downstream issues and doesn’t always address the biggest drivers of spend. 

The more effective model looks different: Optimize usage instead of restricting it. In other words? Get members the right drug at the right time at the right cost. 

When those align, increased engagement doesn’t increase cost—it can actually improve performance. 

Captives help bring this strategy to life in a more meaningful way. With shared data and collective insight, employers can: 

In MJ’s CaptuRe model, this has helped organizations move from reactive decision-making to a more proactive, coordinated approach to pharmacy. 

Pharmacy will continue to be one of the fastest-growing areas of healthcare spend—but the story isn’t just about growth. It’s about how that growth is managed. Because when pharmacy strategy is intentional: More usage doesn’t automatically mean more cost. 

In fact, with the right approach, it can mean the opposite.